Novartis
HC backs Novartis, bars Cipla from selling lung drug copy
By By Jagdeep Worah | 10 Jan 2015
In a blow to those suffering from lung and respiratory diseases, the Delhi High Court on Friday restrained domestic firm Cipla from marketing its affordable generic version of respiratory drug Onbrez, ruling in favour of multinational Novartis
Novartis-GSK business deal gets CCI nod
23 Dec 2014
Cipla wants Novartis’s patents on respiratory drug revoked
30 Oct 2014
Cipla, which launched a generic version of the drug, said Novartis imports "negligible quantity" of its patented drug Onbrez from Switzerland, thereby creating a supply shortage at a time when 15 million Indians needed treatment for chronic obstructive pulmonary disease
CSL to acquire Novartis’ influenza vaccine unit
27 Oct 2014
Novartis, Google tie-up to license “smart lens” technology
16 Jul 2014
Novartis has tied-up with Google to licence its “smart lens” technology for ocular medical uses
